GlassScriptPhysician profile
Lori S Seibert
NPI 1902966419
$1,936.07
in general payments reported to CMS, 2019-2025
23 companies · $301 in 2025
The $301 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $154 · 2021: $187 · 2022: $367 · 2023: $334 · 2024: $475 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $447.81 | 2022-2025 | Azstarys |
| Tris Pharma INC | $315.37 | 2019-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $216.01 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $96.52 | 2021-2025 | |
| Neos Therapeutics, LP | $86.17 | 2020-2024 | Cotempla Xr-Odt |
| Sanofi-Aventis U.S. LLC | $84.11 | 2024-2025 | |
| Cranial Technologies, INC | $83.78 | 2020-2024 | Doc Band |
| Boston Scientific Corporation | $79.53 | 2023-2025 | Varithena Administration Pack |
| Takeda Pharmaceuticals U.S.A., INC. | $68.14 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $54.58 | 2023 | |
| Sanofi Pasteur INC. | $53.77 | 2022-2025 | |
| Adlon Therapeutics L.P. | $45.75 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $44.80 | 2021-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Supernus Pharmaceuticals, INC. | $43.93 | 2021-2024 | Qelbree |
| Collegium Pharmaceutical, INC. | $42.71 | 2025 | Jornay Pm |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $33.10 | 2020 | |
| Shire North American Group INC | $32.69 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.43 | 2025 | Zoryve |
| Nestle Healthcare Nutrition INC. | $17.99 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $17.25 | 2025 | Neffy |
| Alk-Abello, INC | $14.07 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $12.81 | 2019 | |
| Seqirus USA INC | $12.75 | 2023 | Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Seibert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.